Previous close | 1.5800 |
Open | 1.7316 |
Bid | 1.2900 x 200 |
Ask | 2.1500 x 200 |
Day's range | 1.6500 - 1.7800 |
52-week range | 1.4200 - 2.3600 |
Volume | |
Avg. volume | 10,445 |
Market cap | 23.675M |
Beta (5Y monthly) | 0.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.4400 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q1 2024 Cumberland Pharmaceuticals Inc Earnings Call
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands delivered combined revenues of $8.5 million during the first quarter of 2024. The company ended the quarter with $82 million in total assets, $54 million in total liabilities and $27 million of shareholders' equity.
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2024 financial results and provide a company update after the market closes on Tuesday, May 7, 2024.